Corebridge price target lowered to $33 from $34 at Barclays
Barclays analyst Alex Scott lowered the firm’s price target on Corebridge (CRBG) to $33 from $34 and keeps an Overweight rating on the shares. The firm adjusted targets in the life insurance group after revisiting cash flow and private credit exposures to separate “perceived from actual risk.”
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Read More on CRBG:
Disclaimer & DisclosureReport an Issue
- Corebridge price target lowered to $35 from $38 at TD Cowen
- Corebridge price target lowered to $32 from $35 at Morgan Stanley
- Corebridge price target lowered to $36 from $37 at Wells Fargo
- Corebridge Announces $750 Million Share Repurchase from AIG
- Corebridge Financial Earnings Call Highlights Growth, Derisking
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Why Goldman Sachs’ $150 Million XRP Bet Fades Amid Growing Retail Weakness

Serve Robotics and White Castle Launch Autonomous Delivery via Uber Eats

Lenders caution that failed UK 'shadow bank' faces a £1.3bn shortfall

